Neurology
From the Journals
NIH launches HEAL Initiative to combat opioid crisis
HEAL will expand Advancing Clinical Trials in Neonatal Opioid Withdrawal Syndrome (ACT NOW), a pilot study that will assess the prevalence of...
Video
Global MS trends: A chaotic picture with risk as the central theme
It’s tough to draw firm conclusions from the vastly varied studies assessing epidemiologic patterns of MS around the world, says Dr. Alberto...
For Residents
Intellectual disability impedes decision-making in organ transplantation
Cases That Test Your Skills
Depressed and confused, and dizzy while walking the dog
Mr. M, age 73, feels light-headed and has difficulty following conversations. He has a history of depression, cardiovascular disease, and visual...
Conference Coverage
VIDEO: Pills alone not the answer for pain management
SANDESTIN, FLA. – A variety of approaches to pain management is absolutely crucial in the area of opioid abuse.
Pearls
Use psychoeducational family therapy to help families cope with autism
Conference Coverage
Sulforaphane for autism? Maybe
LOS ANGELES –The dietary supplement is showing benefit in a small, ongoing trial, but there are a lot of pills.
From the Editor
10 Recent paradigm shifts in the neurobiology and treatment of depression
The serendipity of half a century ago that hatched hoary theories of the etiology of psychopathology is fading rapidly. Transformative models are...
FDA/CDC
FDA approves Aimovig for migraine prevention
Aimovig is the first FDA-approved treatment to prevent migraines by blocking the calcitonin gene–related peptide receptor.
Cases That Test Your Skills
Young, pregnant, ataxic—and jilted
Ms. M, age 15, thirty-five weeks pregnant and abandoned by her boyfriend, has difficulty walking. No neurologic cause can be found. What could be...
From the Journals
Marketing perks increased opioid prescriptions
Pharma companies may be influencing opioid access via payments to clinicians.
